Increased Levels of Galactose-Deficient Anti-Gal Immunoglobulin G in the Sera of Hepatitis C Virus-Infected Individuals with Fibrosis and Cirrhosis - Wikidata - awgldk - TriplyDB

Increased Levels of Galactose-Deficient Anti-Gal Immunoglobulin G in the Sera of Hepatitis C Virus-Infected Individuals with Fibrosis and Cirrhosis

Increased Levels of Galactose-Deficient Anti-Gal Immunoglobulin G in the Sera of Hepatitis C Virus-Infected Individuals with Fibrosis and Cirrhosis

http://www.wikidata.org/entity/Q27485310

about

Glycomic characterization of prostate-specific antigen and prostatic acid phosphatase in prostate cancer and benign disease seminal plasma fluids Lectin-reactive anti-α-gal in patients with Crohn's disease: correlation with clinical phenotypes N-glycans in liver-secreted and immunoglogulin-derived protein fractions.Glycoproteomics for prostate cancer detection: changes in serum PSA glycosylation patterns.Aleuria Aurantia Lectin (AAL)-reactive immunoglobulin G rapidly appears in sera of animals following antigen exposure Altered functionality of anti-bacterial antibodies in patients with chronic hepatitis C virus infection Human immunodeficiency virus-related microbial translocation and progression of hepatitis C.Quantitative analysis of immunoglobulin subclasses and subclass specific glycosylation by LC-MS-MRM in liver disease.Development of recombinant Aleuria aurantia lectins with altered binding specificities to fucosylated glycans.Novel fucosylated biomarkers for the early detection of hepatocellular carcinoma.Dysfunctional B-cell activation in cirrhosis resulting from hepatitis C infection associated with disappearance of CD27-positive B-cell population.Examination of glycan profiles from IgG-depleted human immunoglobulins facilitated by microscale affinity chromatography.Total serum glycan analysis is superior to lectin-FLISA for the early detection of hepatocellular carcinoma.Microscale purification of antigen-specific antibodies.Elevated core-fucosylated IgG is a new marker for hepatitis B virus-related hepatocellular carcinoma The Doylestown Algorithm: A Test to Improve the Performance of AFP in the Detection of Hepatocellular Carcinoma Site-specific glycoforms of haptoglobin in liver cirrhosis and hepatocellular carcinoma Multiplexed surrogate analysis of glycotransferase activity in whole biospecimens Intrinsic hepatocyte dedifferentiation is accompanied by upregulation of mesenchymal markers, protein sialylation and core alpha 1,6 linked fucosylation Characterization of HIV-HBV coinfection in a multinational HIV-infected cohort.Comparative glycoproteomics: approaches and applications.GlycoFibroTest is a highly performant liver fibrosis biomarker derived from DNA sequencer-based serum protein glycomics.Effects of allergic diseases and age on the composition of serum IgG glycome in children.Increased sialylation of site specific O-glycoforms of hemopexin in liver disease.Analysis of serum protein glycosylation by a differential lectin immunosorbant assay (dLISA).Changes in fucosylation of human seminal IgG and secretory component of IgA in leukocytospermic patients.Intravenous immunoglobulin-based immunotherapy: an arsenal of possibilities for patients and science.The role of sialic acid as a modulator of the anti-inflammatory activity of IgG.Molecular basis for downregulation of C5a-mediated inflammation by IgG1 immune complexes in allergy and asthma.Aberrant serum immunoglobulin G glycosylation in chronic hepatitis B is associated with histological liver damage and reversible by antiviral therapy.IgG subclass and vaccination stimulus determine changes in antigen specific antibody glycosylation in mice.Baseline prevalence and predictors of liver fibrosis among HIV-positive individuals: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.Identification of IgM as a contaminant in lectin-FLISA assays for HCC detection.Clinical severity of visceral leishmaniasis is associated with changes in immunoglobulin g fc N-glycosylation.Glycan Node Analysis: A Bottom-up Approach to Glycomics.Changes in the Glycosylation of Kininogen and the Development of a Kininogen-Based Algorithm for the Early Detection of HCC.Differential antibody glycosylation in autoimmunity: sweet biomarker or modulator of disease activity?Identification of fucosylated Fetuin-A as a potential biomarker for cholangiocarcinoma.B-cell-associated immune profiles in patients with decompensated cirrhosis.

P2860

Q24644593-F27304D7-3B52-4E98-A360-349BEFF8BCD0 Q33956556-AF5C2E27-FEF0-4932-91A7-FB2EEBF04A2C Q34156760-9E6C7782-1426-4077-A9FB-8FA72B67B7B3 Q34381513-3455D7FA-993B-4392-80A0-B92D43092465 Q34424997-49965534-14AD-467C-878C-9F8090C9069A Q34764161-74935F87-7A7F-42DA-AD0A-67BC296BBAC5 Q34775968-0A73BC77-EE86-434A-A580-13BDD9A93811 Q35085189-A205FE9D-660E-4DFA-A810-2291E5B4AE10 Q35450855-A6356509-BD80-475C-BB04-25F3E6FCA415 Q35549677-E6FB8894-E2A1-450B-ABD1-6E41495E1460 Q35633193-54DB87A9-1A50-4326-9CD1-E16F194C6386 Q35874074-9085561E-5CC4-4F42-AED0-548FF1840187 Q36155480-631D9CA1-8624-4EF9-9778-D142A3E66C55 Q36157114-04D7541A-8283-4E49-AE2E-F8B8DB9451D0 Q36256407-D93D0201-3C6E-41F2-A613-673A6B800DFA Q36540674-CCB14B78-EB33-46D2-9BE5-F2C707B74080 Q36832489-1BC543E8-9B32-491A-B4D4-23EC6181B2DD Q36833668-2B94D35B-EFA1-478C-9019-5BAC5CECDA06 Q37027426-E7897B11-DB65-4C21-A62C-40EE24FB1E57 Q37148949-C9DE06F7-C9D1-4B3B-B58F-6E23C8F0E924 Q37171039-347B7920-8925-4645-A70A-7551336AAECC Q37210696-B3FDCC23-72E4-43FE-AE09-4F77400C7D13 Q37248132-710CFCC9-7902-45BB-9599-23020C12DF3A Q37278723-F64B4745-C095-450D-804C-6A1DC402710E Q37357377-0DC8C369-AF14-47CA-8422-163F6FED05BF Q37480161-D8A5C61B-B49B-4158-B563-5B11E0626F4F Q37773248-DD46540F-333D-45E5-B1BD-CC480503C66E Q37995919-B18697B0-BD3A-4635-9BC8-8164D5545083 Q38135285-D3A13B75-865A-45D9-BD37-4617EAFC71B4 Q38976135-B9036780-4BF4-4A48-95AB-49D167362AB0 Q40108236-27B86687-705E-4134-9045-805CB1DEC5CF Q41466494-33B6FEB1-3012-4FB1-BBA7-0BF85F6BF853 Q41479549-B82DD8A8-0464-42FE-B9A2-210BA1F9D0F6 Q41622831-1D2337AB-1B78-47F9-BDBC-A19917B33BB8 Q46188171-FBE46D19-7A55-4ED4-9742-DB016A3D5902 Q46512130-3567B8B1-BFC2-49E0-AB59-67C2331804C1 Q47804590-D7303445-133E-44D1-A308-DE6A6150DED1 Q48351105-CB4270EE-A324-474D-BF38-4CD40B5F6124 Q50741919-265DF567-A71D-4901-8BD1-319465914CEB

P2860

Increased Levels of Galactose-Deficient Anti-Gal Immunoglobulin G in the Sera of Hepatitis C Virus-Infected Individuals with Fibrosis and Cirrhosis

http://www.wikidata.org/entity/Q27485310

description

2008 nî lūn-bûn

@nan

2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

name

Increased Levels of Galactose- ...... ls with Fibrosis and Cirrhosis

@ast

Increased Levels of Galactose- ...... ls with Fibrosis and Cirrhosis

@en

Increased Levels of Galactose- ...... ls with Fibrosis and Cirrhosis

@nl

type

label

Increased Levels of Galactose- ...... ls with Fibrosis and Cirrhosis

@ast

Increased Levels of Galactose- ...... ls with Fibrosis and Cirrhosis

@en

Increased Levels of Galactose- ...... ls with Fibrosis and Cirrhosis

@nl

prefLabel

Increased Levels of Galactose- ...... ls with Fibrosis and Cirrhosis

@ast

Increased Levels of Galactose- ...... ls with Fibrosis and Cirrhosis

@en

Increased Levels of Galactose- ...... ls with Fibrosis and Cirrhosis

@nl

P1433

Q27485310-BF7CEE62-2DE9-406D-B442-8546487AABD6

P1476

Q27485310-4F9D73FC-3F3B-49C9-8914-70BA17116A9E

P2093

Q27485310-733AE6AF-4303-4FE9-B9C2-9441F2ECECA9

Q27485310-8260E89C-9F4C-4E82-BB00-25AC048EF9DF

Q27485310-8A0615C5-8FBE-4E7B-8F5B-E32B2A3F456C

Q27485310-97B7B5A8-4EEB-499F-9942-A909C9C81395

Q27485310-9AF7A599-360E-4B6D-BCCB-AFC674B31243

Q27485310-A6DEC2AA-F7E9-461A-8D49-305F62E50388

Q27485310-BAEBB948-7CD6-4F58-BEA8-876F81D40E44

Q27485310-CF49D06D-F921-409A-A350-3CB6BE607A1A

Q27485310-D26B2EC8-989E-43EE-8523-A2E3FB9409F4

Q27485310-F69D0CC1-4CAF-405F-B0BA-07502F1C05BE

P2860

Q27485310-0318F023-35A4-4757-B717-3DDFB15530E5

Q27485310-079CD7BA-25F3-4928-B623-332FED2C69D9

Q27485310-09C52DE5-6AD4-4870-BBD1-59222C5599AB

Q27485310-1A6D20E8-4234-47D3-AC68-5E061EC11D05

Q27485310-21094192-77FC-4AF1-9FA8-96507F538CCB

Q27485310-27C76897-EB87-499E-B314-226FC260902D

Q27485310-4AD12EC2-E6C0-4163-95F9-9942B00BEE91

Q27485310-54ED788C-660A-4EF8-B412-2EDA456FBD4D

Q27485310-58867AE8-0C90-4F4B-BFC5-B5D8101B985D

Q27485310-75941F0E-B08B-4213-9F4D-BE776431A21B

P304

Q27485310-8443E035-D22C-40EB-B1BC-56D7D04727FA

P31

Q27485310-DC4BAD89-23E3-451C-97C7-6E8B09A3C55D

P3181

Q27485310-5E70C75B-BC78-4DB8-92A4-6475F3FF64B3

P356

Q27485310-EA4FFD13-736F-484E-A57A-B4B6FEA235DA

P433

Q27485310-789E6AF1-2775-49B3-95A6-ED7635260CE2

P478

Q27485310-8A8A147A-F573-46F7-AB0C-B640A8988084

P577

Q27485310-E1D3295A-6A42-40CE-929B-47F3BAB271D7

P5875

Q27485310-4687BF18-1AE1-4A42-AF41-FA8EA30F8476

P698

Q27485310-5D82F476-C93B-48A9-9F9A-47B10BEAC937

P921

Q27485310-93C35206-DD46-44DD-B228-84CB306B4C1B

P932

Q27485310-CB96CD20-BE6B-47CD-94DF-2F01FE7FFBC1

P3181

P356

P1433

Journal of Virology

P1476

Increased Levels of Galactose- ...... ls with Fibrosis and Cirrhosis

@en

P2093

Anand S Mehta

http://www.w3.org/2001/XMLSchema#string

Jonathan Krakover

http://www.w3.org/2001/XMLSchema#string

Jorge A Marrero

http://www.w3.org/2001/XMLSchema#string

Lucy Rodemich

http://www.w3.org/2001/XMLSchema#string

Mary Ann Comunale

http://www.w3.org/2001/XMLSchema#string

Mengjun Wang

http://www.w3.org/2001/XMLSchema#string

Ramila Philip

http://www.w3.org/2001/XMLSchema#string

Raymond A Dwek

http://www.w3.org/2001/XMLSchema#string

Ronald E Long

http://www.w3.org/2001/XMLSchema#string

Timothy M Block

http://www.w3.org/2001/XMLSchema#string

P2860

Epidemiology of hepatitis C

Histological grading and staging of chronic hepatitis

Identification of highly fucosylated N-linked oligosaccharides from the human parotid gland.

Lectin capture strategies combined with mass spectrometry for the discovery of serum glycoprotein biomarkers.

Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans.

Glycoproteins: rapid sequencing technology for N-linked and GPI anchor glycans.

The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy.

Results of lamivudine trials in Asia.

Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity.

Management of hepatitis B patients with antiviral resistance.

P304

1259-70

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

571895

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/JVI.01600-07

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

82

http://www.w3.org/2001/XMLSchema#string

P577

2008-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5801865

http://www.w3.org/2001/XMLSchema#string

P698

18045939

http://www.w3.org/2001/XMLSchema#string

P921

liver cirrhosis

P932

2224448

http://www.w3.org/2001/XMLSchema#string